We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.23 | 0.53% | 43.58 | 43.68 | 43.27 | 43.58 | 4,048,068 | 01:00:00 |
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|||
a)
|
Name
|
Dr K Slaoui
|
||
b)
|
Position/status
|
PCA of Dr M M Slaoui (Chairman, Global Vaccines)
|
||
c)
|
Initial notification /
amendment
|
Initial notification
|
||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|||
a)
|
Name
|
GlaxoSmithKline plc
|
||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|||
a)
|
Description
of
the
financial
instrument
|
American Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
||
b)
|
Nature
of
the
transaction
|
An increase of 4 ADSs following the notional allocation of ADSs on
22 March 2017, at a price of $42.28 per ADS, as a result of the
revaluation of the cash element of the notional investment held
within the GSK 401(K) plan.
|
||
c)
|
Price(s)
and
volume(s)
|
Price(s)
|
Volume(s)
|
|
$42.28
|
4
|
|||
|
||||
|
||||
d)
|
Aggregated
information
Aggregated
volume
Price
|
n/a (single transaction)
|
||
e)
|
Date of
the
transaction
|
2017-03-22
|
||
f)
|
Place
of
the
transaction
|
n/a
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: March
23, 2017
|
|
|
|
|
By: VICTORIA
WHYTE
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions